AI assistant
AbbVie Inc. — Director's Dealing 2025
May 13, 2025
29755_dirs_2025-05-13_7b81626c-89eb-442a-83e4-4abf714ebe4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2025-05-09
Reporting Person: RAPP EDWARD J (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-09 | Common Stock, $0.01 par value | A | 1203 | — | Acquired | 34458 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.01 par value | 10388 | Indirect |
Footnotes
F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2: Includes an additional 1,899 shares which, due to an administrative error, were inadvertently omitted from a previously filed form.
F3: The reporting person disclaims beneficial ownership of all securities held by his wife.